Capcyte Biothérapeutique

Propulsé - BioTech | Hiver 2025

About the company

Capcyte’s mission is to make cardiovascular implants safer through our unique biomolecular coating. We are able to treat most existing implants to enhance their healing potential, thereby limiting complications for patients.

The founders

Hugo Level
Président & CEO
Mariève Boulanger
Directrice finance et administration
Marc-Antoine Campeau
Directeur Technologie
Corinne A Hoesli
Directrice scientifique
Digital Health

Innov2Learn

Hiver 2017
CleanTech

SPARK Microsystems International inc

Été 2017
Vope Medical - Logo

Vopemed

Automne 2021